Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 125

2.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C, Comabella M, Nos C, Arévalo MJ, Negrotto L, Galán I, Vidal-Jordana A, Castilló J, Palavra F, Simon E, Mitjana R, Auger C, Sastre-Garriga J, Montalban X.

Brain. 2015 Jul;138(Pt 7):1863-74. doi: 10.1093/brain/awv105. Epub 2015 Apr 21.

PMID:
25902415
4.

A comparison of risperidone and buspirone for treatment of behavior disorders in children with phenylketonuria.

Fayyazi A, Salari E, Khajeh A, Gajarpour A.

Iran J Child Neurol. 2014 Fall;8(4):33-8.

5.

Significant clinical worsening after natalizumab withdrawal: Predictive factors.

Vidal-Jordana A, Tintoré M, Tur C, Pérez-Miralles F, Auger C, Río J, Nos C, Arrambide G, Comabella M, Galán I, Castilló J, Sastre-Garriga J, Rovira A, Montalban X.

Mult Scler. 2015 May;21(6):780-5. doi: 10.1177/1352458514549401. Epub 2014 Nov 12.

PMID:
25392320
6.

Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases.

He X, Zhao M, Bi X, Sun L, Yu X, Zhao M, Zang W.

Br J Pharmacol. 2014 Nov 7. doi: 10.1111/bph.13010. [Epub ahead of print]

PMID:
25378088
7.

PLAY Project Home Consultation intervention program for young children with autism spectrum disorders: a randomized controlled trial.

Solomon R, Van Egeren LA, Mahoney G, Quon Huber MS, Zimmerman P.

J Dev Behav Pediatr. 2014 Oct;35(8):475-85. doi: 10.1097/DBP.0000000000000096.

8.

The association between congenital anomalies and autism spectrum disorders in a Finnish national birth cohort.

Timonen-Soivio L, Vanhala R, Malm H, Leivonen S, Jokiranta E, Hinkka-Yli-Salomäki S, Gissler M, Brown AS, Sourander A.

Dev Med Child Neurol. 2015 Jan;57(1):75-80. doi: 10.1111/dmcn.12581. Epub 2014 Sep 8.

PMID:
25200584
9.

The clinical spectrum of anxiety in Parkinson's disease.

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ.

Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937. Review.

PMID:
25043800
10.

An examination of social interaction profiles based on the factors measured by the screen for social interaction.

Mahoney EB, Breitborde NJ, Leone SL, Ghuman JK.

Res Dev Disabil. 2014 Oct;35(10):2487-94. doi: 10.1016/j.ridd.2014.06.008. Epub 2014 Jun 30.

PMID:
24992448
11.

A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample.

Kim YS, Fombonne E, Koh YJ, Kim SJ, Cheon KA, Leventhal BL.

J Am Acad Child Adolesc Psychiatry. 2014 May;53(5):500-8. doi: 10.1016/j.jaac.2013.12.021. Epub 2014 Jan 21.

12.

[Aspects of quality of life of residents of a nursing oasis from the perspectives of relatives and nurses- qualitative results of an evaluation study].

Brandenburg H, Adam-Paffrath R, Güther H.

Pflege. 2014 Apr;27(2):69-80. doi: 10.1024/1012-5302/a000347. German.

PMID:
24670540
13.

Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.

Río J, Rovira A, Tintoré M, Sastre-Garriga J, Castilló J, Auger C, Nos C, Comabella M, Tur C, Vidal Á, Montalbán X.

Mult Scler. 2014 Oct;20(12):1602-8. doi: 10.1177/1352458514527863. Epub 2014 Mar 12.

PMID:
24622350
14.

Prognostic factors of neurocognitive and functional outcomes in junior and senior elderly patients with traumatic brain injury undergoing disability evaluation or appointed disability evaluation.

Jung YJ, Kim OL, Kim MS, Cheon EJ, Bai DS.

J Korean Neurosurg Soc. 2014 Jan;55(1):18-25. doi: 10.3340/jkns.2014.55.1.18. Epub 2014 Jan 31.

15.

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X.

PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013.

16.

Suicidal behaviour in adolescents and young adults with ASD: findings from a systematic review.

Hannon G, Taylor EP.

Clin Psychol Rev. 2013 Dec;33(8):1197-204. doi: 10.1016/j.cpr.2013.10.003. Epub 2013 Oct 15. Review.

PMID:
24201088
17.

Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.

Goncalves DA, Camparis CM, Speciali JG, Castanharo SM, Ujikawa LT, Lipton RB, Bigal ME.

J Orofac Pain. 2013 Fall;27(4):325-35. doi: 10.11607/jop.1096.

PMID:
24171182
18.

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.

Ramo-Tello C, Grau-López L, Tintoré M, Rovira A, Ramió i Torrenta L, Brieva L, Cano A, Carmona O, Saiz A, Torres F, Giner P, Nos C, Massuet A, Montalbán X, Martínez-Cáceres E, Costa J.

Mult Scler. 2014 May;20(6):717-25. doi: 10.1177/1352458513508835. Epub 2013 Oct 21.

PMID:
24144876
19.

No sex differences in neuropsychological performance in first episode psychosis patients.

Ayesa-Arriola R, Rodriguez-Sanchez JM, Gomez-Ruiz E, Roiz-Santiáñez R, Reeves LL, Crespo-Facorro B.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:149-54. doi: 10.1016/j.pnpbp.2013.09.009. Epub 2013 Sep 25.

PMID:
24075821
20.

Clinical impact of early brain atrophy in clinically isolated syndromes.

Pérez-Miralles F, Sastre-Garriga J, Tintoré M, Arrambide G, Nos C, Perkal H, Río J, Edo MC, Horga A, Castilló J, Auger C, Huerga E, Rovira A, Montalban X.

Mult Scler. 2013 Dec;19(14):1878-86. doi: 10.1177/1352458513488231. Epub 2013 May 7.

PMID:
23652215
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk